Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 23, 16:00
2029.50
44.65 (2.25%)
VOLUME 54,946
LIVE
NSE
Aug 23, 15:59
2030.95
46.8 (2.36%)
VOLUME 809,996
News on Dr Reddys Laboratories
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Dr Reddy's Labs, Dewan Housing Finance; sell PC Jeweller: Rajat Bose

2.39 pm | 22 Aug 2017 |  Source: CNBC-TV18

Rajat Bose of rajatkbose.com is of the view that one can buy Dr Reddy's Labs and Dewan Housing Finance and sell PC Jeweller....

Dr Reddy's Laboratories up 1% on out-licensing of DFD-06 to Encore Dermatology

11.15 am | 22 Aug 2017 |  Source: Moneycontrol.com

The said drug is intended to be used for the treatment of moderate to severe plaque psoriasis....

Dr. Reddy's Laboratories out-license DFD-06 to Encore Dermatology

10.59 am | 22 Aug 2017 |  Source: Moneycontrol.com

Dr Reddy’s Laboratories through its wholly owned subsidiary Promius Pharma LLC, announced today that it has out-licensed the future development, man...

Avoid Dr Reddy's Laboratories, says Ashwani Gujral 

5.18 pm | 14 Aug 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com is of the view that one may avoid Dr Reddy's Laboratories....

US law firms threaten class action suit against Dr Reddy's 

3.39 pm | 12 Aug 2017 |  Source: CNBC-TV18

In what could be a big setback for Indian pharma major Dr Reddy's Labs, US based law firms have threatened a class action suit against the company...

German regulator denies GMP nod to DRL's Bachupally Unit 2

3.50 pm | 10 Aug 2017 |  Source: PTI

The communication came after a recent inspection of the plant, Dr Reddy's Laboratories said in a filing to BSE....

Dr Reddys Laboratories’ subsidiary receives communication from Regulatory Authority of Germany

2.57 pm | 10 Aug 2017 |  Source: Moneycontrol.com

betapharm Arzneimittel GmbH, Germany (our wholly-owned subsidiary) received a communication from the Regulatory Authority of Germany (Regierung von Ob...

Strong support for Nifty at 9968: 4 stocks to buy, sell today: Prakash Gaba 

7.43 am | 04 Aug 2017 |  Source: Moneycontrol.com

According to Prakash Gaba of prakashgaba.com, the larger trend for Nifty is still intact, however some slide is not rule out and there exists a strong...

Hold Dr. Reddys Laboratories; target of Rs 2520: Edelweiss

6.22 pm | 31 Jul 2017 |  Source: Moneycontrol.com

Edelweiss is bullish on Dr. Reddys Laboratories has recommended Hold rating on the stock with a target price of Rs 2520 in its research report dated J...

Hold Dr. Reddy's Laboratories; target of Rs 2523: KRChoksey

6.22 pm | 31 Jul 2017 |  Source: Moneycontrol.com

KRChoksey' is bullish on Dr. Reddy's Laboratories has recommended Hold rating on the stock with a target price of Rs 2523 in its research repo...

Sell Dr. Reddy’s Labs; target of Rs 2275: HDFC Securities

4.45 pm | 31 Jul 2017 |  Source: Moneycontrol.com

HDFC Securities recommended sell rating on Dr. Reddy’s Labs with a target price of Rs 2275 in its research report dated July 28, 2017....

After 'perfect storm', Dr Reddy's seeks recovery this fiscal

11.35 am | 30 Jul 2017 |  Source: PTI

The Hyderabad-based firm saw its consolidated revenue dip by 9 per cent last fiscal to Rs 14,367.6 crore as it faced a multitude of issues, including ...

Dr Reddy's Labs can slide to Rs 2425, says Prakash Gaba 

2.59 pm | 28 Jul 2017 |  Source: CNBC-TV18

Prakash Gaba of prakashgaba.com is of the view that Dr Reddy's Labs can slide to Rs 2425....

Dr Reddy's Lab shares extend slide, tank over 6%

12.31 pm | 28 Jul 2017 |  Source: PTI

Shares of Dr Reddy's Laboratories today tanked over 6 percent after the drug firm reported a 56.61 percent dip in consolidated net profit for the ...

Dr Reddy’s tanks 6% on dismal Q1; brokerages turn cautious on stock

12.16 pm | 28 Jul 2017 |  Source: Moneycontrol.com

Say headwinds in US hit financials, highlight further risks in terms of remediation delays at its plants....

Dr Reddy's enters licensing pact with CHD Bioscience to develop and commercialise latter's antibiotic gel

6.18 pm | 27 Jul 2017 |  Source: Moneycontrol.com

Under the terms of the agreement, DRL would receive equity in CHD valued at USD 30 million upon an IPO of CHD or a minimum of USD 30 million in cash w...

Dr Reddy's profit drops 57% in Q1 to Rs 66 cr due to lacklustre US and India biz 

2.50 pm | 27 Jul 2017 |  Source: Moneycontrol.com

Drug maker Dr Reddy's Laboratories on Thursday said its net profit dropped 57 percent in the quarter ended June on account o falling sales in US a...

Dr Reddy's Labs Q1 profit growth may be over 2-fold on strong operational numbers 

8.38 am | 27 Jul 2017 |  Source: CNBC-TV18

Revenue is seen rising 4.6 percent year-on-year to Rs 3,383 crore in June quarter, according to average of estimates of analysts polled by CNBC-TV18....

USFDA observations beneficial in long run: Dr Reddy's

7.45 am | 24 Jul 2017 |  Source: PTI

"The remedial actions triggered by the USFDA observations are unmistakably beneficial to us in the long run and it has helped us accelerate the pace o...

Hold Dr Reddys; target of Rs 2660: Edelweiss

6.37 pm | 12 Jul 2017 |  Source: Moneycontrol.com

Edelweiss' is bullish on Dr Reddys has recommended Hold rating on the stock with a target price of Rs 2660 in its research report dated July 10, 2...

1 2 3 4 5
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.